Seroprevalence of varicella antibodies among pregnant women in Lyon-France

European Journal of Epidemiology

Volumn 22, Issue 6, 2007, Pages 405-409

  Saadatian Elahi, M ^a,b,c   Mekki, Y ^d   Del Signore, C ^a,b,c   Lina, B ^d   Derrough, T ^e   Caulin, E ^e   Thierry, J ^f   Vanhems, P ^a,b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e SANOFI PASTEUR   (France)

^f Clinique Charcot   (France)

Author keywords

France; Lyon; Pregnancy; Seroprevalence; Varicella; VZV

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; FEMALE; FRANCE; HERPES ZOSTER; HUMAN; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY; MAJOR CLINICAL STUDY; PREDICTIVE VALIDITY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIMIPARA; QUESTIONNAIRE; SEROLOGY; SEROPREVALENCE;

ADULT; ANTIBODIES, VIRAL; CHICKENPOX; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS;

EID: 34447304337     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-007-9136-z     Document Type: Article

References (24)

1. Khoshnood B, Debruyne M, Lancon F, et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 2006;25:41-4.
2. Sauerbrei A. Varicella-zoster virus infections in pregnancy. Intervirology 1998;41:191-6.
3. Mirlesse V. Varicelle pergravidique : place de l'imagerie dans le dépistage de l'atteinte fœtale. Revue du praticien Gynécologie et obstétrique 2004; 83:44-5.
4. Bonmarin I, Ndiaye B, Seringe E, Levy-Bruh D. Epidémiologie de la varicelle en France. Bull Epid Hebd 2005;8:29-32.
5. Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 1986;314:1542-6.
6. Pastuszak AL, Levy M, Schick B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994;330:901-5.
7. Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol 2001;21:545-9.
8. Haddad J, Gut JP, Lokiec F. Prevention of foetal and neonatal transmission of the varicella-zoster virus. Pathol Biol (Paris) 1992;40:724-8.
9. Berrebi A, Assouline C, Ayoubi JM, et al. Varicelle et grossesse. Arch pediatr 1998;5:79-83.
10. Prober CG, Gershon AA, Grose C, et al. Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J 1990;9:865-9.
11. Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 1989;2:371-3.
12. Gatchalian S, Tabora C, Bermal N, et al. Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old. Am J Trop Med Hyg 2004;70:273-7.
13. Alanen A, Kahala K, Vahlberg T, et al. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 2005;112:50-6.
14. Linder N, Ferber A, Kopilov U, et al. Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther 2001;16:423-6.
15. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343(8912):1548-51.
16. Salleras L, Dominguez A, Vidal J, et al. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 2000;19:183-8.
17. Wutzler P, Farber I, Wagenpfeil S, et al. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001;20:121-4.
18. Dayan GH, Panero MS, Debbag R, et al. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol 2004;42:5698-5704.
19. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998;3:886-890.
20. Goldberg JM, Ziel HK, Burchette R. Evaluation of varicella immune status in an obstetric population in relation to place of birth. Am J Perinatol 2002;19:387-394.
21. Plourd DM, Austin K. Correlation of a reported history of chickenpox with seropositive immunity in pregnant women. J Reprod Med 2005;50:779-783.
22. Knowles SJ, Grundy K, Cahill I, Cafferkey MT. Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health 2004;7:344-8.
23. Saadatian-Elahi M, Mekki Y, Del Signore C, Lina B, Derrough T, Caulin E, Vanhems P. Séroprévalence de la varicelle chez les femmes enceintes dans le Rhône. BEH 2006;39:294-6.
24. Suarez Gonzalez A, Otero Guerra L, De La Guerra GV, et al. Varicella and parvovirus B19 immunity among pregnant women in Gijon, Spain. Med Clin (Barc) 2002;119:171-3.